Glycosylation defects: A new mechanism for muscular dystrophy?

Human Molecular Genetics

Volumn 12, Issue REV. ISS. 2, 2003, Pages

  Grewal, Prabhjit K ^a,b   Hewitt, Jane E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGRIN; DYSTROGLYCAN; FUKUTIN RELATED PROTEIN; GLYCOSYLTRANSFERASE; LAMININ; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

AGYRIA; ALLELE; CENTRAL NERVOUS SYSTEM; ENZYME GLYCOSYLATION; EXTRACELLULAR MATRIX; EYE DISEASE; GENE DELETION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC IDENTIFICATION; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN TARGETING; RETINA DISEASE; REVIEW; WALKER WARBURG SYNDROME;

EID: 0141925704     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg272     Document Type: Review

References (72)

1. Durbeej, M. and Campbell, K.P. (2002) Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr. Opin. Gen. Dev., 12, 349-361.
2. Campbell, K.P. and Allamand, V. (2000) Animal models for muscular dystrophy: valuable tools for the development of therapies. Hum. Mol. Genet., 9, 2459-2467.
3. Blake, D.J., Weir, A., Newey, S.E. and Davies, K.E. (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev., 82, 291-329.
4. Dalkilic, I. and Kunkel, L.M. (2003) Muscular dystrophies: genes to pathogenesis. Curr. Opin. Gen. Dev., 13, 231-238.
5. Ervasti, J.M. (2003) Costameres: The Achilles' heel of herculean muscle. J. Biol. Chem., 278, 13591-13594.
6. Lowe, J.B. and Marth, J.D. (2003) A genetic approach to mammalian glycan function. Annu. Rev. Biochem., 72, 643-691.
7. Grünewald, S., Matthijs, G. and Jaeken, J. (2002) Congenital disorders of glycosylation: A review. Pediatr Res., 52, 618-624.
8. Jurado, L.A.P., Coloma, A. and Cruces, J. (1999) Identification of a human homologue of the Drosophila rotated abdomen gene (POMT1) encoding a putative O-mannosyl-transferase, and assignment to human chromosome 9q34.1. Genomics, 58, 171-180.
9. Endo, T. (1999) O-mannosyl glycans in mammals. Biochim. Biophys. Acta, 1473, 237-246.
10. Martin-Blanco, E. and Garcia-Bellido, A. (1996) Mutations in the rotated abdomen locus affect muscle development and reveal an intrinsic asymmetry in Drasophila. Proc. Natl Acad. Sci. USA, 93, 6048-6052.
11. Beltrán-Valero de Benabé, D., Currier, S., Steinbrecher, A., Celli, J., van Beusekom, E., van der Zwaag, B., Kayserili, H., Merlini, L., Chitayat, D., Dobyns, W.B. et al. (2002) Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am. J. Hum. Genet., 71, 1033-1043.
12. Cormand, B., Pihko, H., Bayes, M., Valanne, L., Santavuori, P., Talim, B., Gershoni-Baruch, R., Ahmad, A., van Bokhoven, H., Brunner, H.G. et al. (2001) Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease. Neurology, 56, 1059-1069.
13. Dobyns, W.B., Pagon, R.A., Armstrong, D., Curry, C.J., Greenberg, F., Grix, A., Holmes, L.B., Laxova, R., Michels, V.V. and Robinow, M. (1989) Diagnostic criteria for Walker-Warburg syndrome. Am. J. Med. Genet., 32, 195-210.
14. Beltrán-Valero de Bernabé, D., van Bokhovan, H., van Beusekom, E., Van den Akker, W., Kant, S., Dobyns, W.B., Cormand, B., Currier, S., Hamel, B., Talim, B. et al. (2003) A homozygous nonsense mutation in the Fukutin gene causes a Walker-Warburg Syndrome phenotype. J. Med. Genet., in press.
15. Willer, T., Amselgruber, W., Deutzmann, R. and Strahl, S. (2002) Characterization of POMT2, a novel member of the PMT protein O-mannosyltransferase family specifically localized to the acrosome of mammalian spermatids. Glycobiology, 12, 771-783.
16. Yoshida, A., Kobayashi, K., Manya, H., Taniguchi, K., Kano, H., Mizuno, M., Inazu, T., Mitsuhashi, H., Takahashi, S., Takeuchi, M. et al. (2001) Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev. Cell, 1, 717-724.
17. Zhang, W.L., Betel, C. and Schachter, H. (2002) Cloning and expression of a novel UDP-GlcNAc:alpha-D-mannoside beta 1,2-N-acetylglucosaminyltransferase homologous to UDP-GlcNAc:alpha-3-D-mannoside beta 1-2-N-acetylglucosaminyltransferase I. Biochem. J., 361, 153-162.
18. Taniguchi, K., Kobayashi, K., Saito, K., Yamanouchi, H., Ohnuma, A., Hayashi, Y.K., Manya, H., Jin, D.K., Lee, M., Parano, E. et al. (2003) Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease. Hum. Mol. Genet., 12, 527-534.
19. Takahashi, S., Sasaki, T., Manya, H., Chiba, Y., Yoshida, A., Mizuno, M., Ishida, H., Ito, F., Inazu, T., Kotani, N. et al. (2002) A new β1,2-N-acetylglucosaminyltransferase that may play a role in the biosynthesis of mammalian O-mannosyl glycans. Glycobiology, 11, 37-45.
20. Kobayashi, K., Nakahori, Y., Miyake, M., Matsumura, K., Kondo-Iida, E., Nomura, Y., Segawa, M., Yoshioka, M., Saito, K., Osawa, M. et al. (1998) An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature, 394, 388-392.
21. Toda, T., Kobayashi, K., Kondo-Iida, E., Sasaki, J. and Nakamura, Y. (2000) The Fukuyama congenital muscular dystrophy story. Neuromusc. Dis., 10, 153-159.
22. Silan, F., Yoshioka, M., Kobayashi, K., Simsek, E., Tunc, M., Alper, M., Cam, M., Guven, A., Fukuda, Y., Kinoshita, M. et al. (2003) A new mutation of the fukutin gene in a non-Japanese patient. Ann. Neurol., 53, 392-396.
23. Toda, T., Yoshioka, M., Nakahori, Y., Kanazawa, I., Nakamura, Y. and Nakagome, Y. (1995) Genetic identity of Fukuyama type congenital muscular dystrophy and Walker-Warburg syndrome. Ann. Neurol., 37, 99-101.
24. Takeda, S., Kondo, M., Sasaki, J., Kurahasi, H., Kano, H., Arai, K., Misaki, K., Fukui, T., Kobayashi, K., Tachikawa, M. et al. (2003) Fukutin is required for maintenance of muscle integrity, cortical histiogenesis and normal eye development. Hum. Mol. Genet., 12, 1449-1459.
25. Aravind, L. and Koonin, E.V. (1999) The fukutin protein family - predicted enzymes modifying cell-surface molecules. Curr. Biol., 9, R836-R837.
26. Esapa, C.T., Benson, M.A., Schroder, J.E., Martin-Rendon, E., Brockington, M., Brown, S.C., Muntoni, F., Kroger, S. and Blake, D.J. (2002) Functional requirements for fukutin-related protein in the Golgi apparatus. Hum. Mol. Genet., 11, 3319-3331.
27. Brockington, M., Blake, D.J., Prandini, P., Brown, S.C., Torelli, S., Benson, M.A., Ponting, C.P., Estournet, B., Romero, N., Voit, T et al. (2001) A novel glycosyltransferase is mutated in a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan. Am. J. Hum. Genet., 69, 1198-1209.
28. Brockington, M., Yuva, Y., Prandini, P., Brown, S.C., Torelli, S., Benson, M.A., Herrmann, R., Anderson, L.V.B., Bashir, R., Burgunder, J.-M. et al. (2001) Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum. Mol. Genet., 10, 2851-2859.
29. Mercuri, E., Brockington, M., Straub, V., Quijano-Roy, S., Yuva, Y., Herrmann, R., Brown, S.C., Torelli, S., Dubowitz, V., Blake, D.J. et al. (2003) Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann. Neurol., 53, 537-542.
30. Poppe, M., Cree, L., Bourke, J., Eagle, M., Anderson, L.V.B., Birchall, D., Brockington, M., Buddles, M., Busby, M., Muntoni, F. et al. (2003) The phenotype of limb-girdle muscular dystrophy type 2I. Neurology, 60, 1246-1251.
31. Topaloglu, H., Brockington, M., Yuva, Y., Talim, B., Haliloglu, G., Blake, D., Torelli, S., Brown, S.C. and Muntoni, F. (2003) FKRP gene mutations cause congenital muscular dystrophy, mental retardation, and cerebellar cysts. Neurology, 60, 988-992.
32. Peyrard, M., Seroussi, E., Sandberg-Nordqvist, A.-C., Xie, Y.-G., Han, E-Y., Fransson, I., Collins, J., Dunham, I., Kost-Alimova, M. and Imreh, S. (1999) The human LARGE gene from 22q12.3-q13.1 is anew distinct member of the glycosyltransferase gene family. Proc. Natl Acad. Sci. USA, 96, 598-603.
33. Grewal, P.K. and Hewitt, J.E. (2002) Mutation of Large, which encodes a putative glycosyltransferase, in an animal model of muscular dystrophy. Biochim. Biophys. Acta, 1573, 216-224.
34. Grewal, P.K., Holzfeind, P.J., Bittner, R.E. and Hewitt, J.E. (2001) Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse. Nat. Genet., 28, 151-154.
35. Lane, P.W., Beamer, T.C. and Myers, D.D. (1976) Myodystrophy, a new myopathy on chromosome 8 of the mouse. J. Heredity, 67, 135-138.
36. Mathews, K.D., Rapisarda, D., Bailey, H.L., Murray, J.C., Schleper, R.L. and Smith, R. (1995) Phenotypic and pathological evaluation of the myd mouse, a candidate model for facioscapulohumeral dystrophy. J. Neuropath. Exp. Neurol., 54, 601-606.
37. Rayburn, H.B. and Peterson, A.C. (1978) Naked axons in myodystrophic mice. Brain Res., 146, 380-384.
38. myd mouse defines a natural model for glycosylation-deficient muscle-eye-brain disorders. Hum. Mol. Genet., 11, 2673-2687.
39. Michele, D.E., Barresi, R., Kanagawa, M., Saito, F., Cohn, R.D., Satz, J.S., Dollar, J., Nishino, I., Kelley, R.I., Somer, H. et al. (2002) Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature, 418, 417-421.
40. Heinrichs, D.E., Monteiro, M.A., Perry, M.B. and Whitfield, C. (1998) The assembly system for the lipopolysaccharide R2 core-type of Escherichia coli is a hybrid of those found in Escherichia coli K-12 and Salmonella enterica. J. Biol. Chem., 273, 8849-8859.
41. Sasaki, K., Kurata-Miura, K., Ujita, M., Angata, K., Nakagawa, S., Sekine, S., Nishi, T. and Fukuda, M. (1997) Expression cloning of cDNA encoding a human β-1,3-N-acetylglucosaminyltransferase that is essential for poly-N-acetyllactosamine synthesis. Proc. Natl Acad. Sci. USA, 94, 14294-14299.
42. Hayashi, Y.K., Ogawa, M., Tagawa, K., Noguchi, S., Ishihara, T., Nonaka, I. and Arahata, K. (2001) Selective deficiency of α-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology, 57, 115-121.
43. Kano, H., Kobayashi, K., Herrmann, R., Tachikawa, M., Manya, H., Nishino, I., Nonaka, I., Straub, V., Talim, B., Voit, T. et al. (2002) Deficiency of α-dystroglycan in Muscle-Eye-Brain disease. Biochem. Biophys. Res. Comm., 291, 1283-1286.
44. Henry, M.D. and Campbell, K.P. (1999) Dystroglycan inside and out. Curr. Opin. Cell Biol., 11, 602-607.
45. Sugita, S., Saito, F., Tang, J., Satz, J., Campbell, K. and Südhof, T.C. (2001) A stoichiometric complex of neurexins and dystroglycan in brain. J. Cell Biol., 154, 435-445.
46. Cohn, R.D. and Campbell, K.P. (2000) Molecular basis of muscular dystrophies. Muscle & Nerve, 23, 1456-1471.
47. Blake, D.J. and Kröger, S. (2000) The neurobiology of Duchenne muscular dystrophy: learning lessons from muscle? TINs, 23, 92-99.
48. Blank, M., Blake, D.J. and Kröger, S. (2002) Molecular diversity of the dystrophin-like protein complex in the developing and adult avian retina. Neuroscience, 111, 259-273.
49. Durbeej, M., Larsson, E., Ibraghimov-Beskrovnaya, O., Roberds, S.L., Campbell, K.P. and Ekblom, P. (1995) Non-muscle α-dystroglycan is involved in epithelial development. J. Cell Biol., 130, 79-91.
50. Montanaro, F., Carbonetto, S., Campbell, K.P. and Lindenbaum, M. (1995) Dystroglycan expression in the wild type and mdx mouse neural retina: synaptic colocalisation with dystrophin, dystrophin-related protein but not with laminin. J. Neurosci. Res., 42, 528-538.
51. Williamson, R.A., Henry, M.D., Daniels, K.J., Hrstka, R.F., Lee, C.J., Sunada, Y., Ibraghimov-Beskrovnaya, O. and Campbell, K.P. (1997) Dystroglycan is essential for early embryonic development: disruption of Reichart's membrane in Dag 1-null mice. Hum. Mol. Genet., 6, 831-841.
52. Côté, P.D., Moukhles, H., Lindebaum, M. and Carbonetto, S. (1999) Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nature Genet., 23, 338-342.
53. Cohn, R.D., Henry, M.D., Michele, D.E., Barresi, R., Saito, F., Moore, S.A., Flanagan, J.D., Skwarchuk, M.W., Robbins, M.E., Mendell, J.R. et al. (2002) Disruption of Dag1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell, 110, 639-648.
54. Moore, S.A., Saito, F., Chen, J., Michele, D.E., Henry, M.D., Messing, A., Cohn, R.D., Ross-Barta, S.E., Westra, S., Williamson, R.A. et al. (2002) Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature, 418, 422-425.
55. Ibraghimov-Beskrovnaya, O., Ervasti, J.M., Leveille, C.J., Slaughter, C.A., Sernett, S.W. and Campbell, K.P. (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature, 355, 696-702.
56. Ibraghimov-Beskrovnaya, O., Milatovich, A., Ozcelik, T., Yang, B., Koepnick, K., Francke, U. and Campbell, K.P. (1993) Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue-specific isoforms and chromosomal localization. Hum. Mol. Genet, 2, 1651-1657.
57. Durbeej, M., Henry, M.D. and Campbell, K.P. (1998) Dystroglycan in development and disease. Curr. Opin. Cell Biol., 10, 594-601.
58. Ervasti, J.M. and Campbell, K.P. (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol., 122, 809-823.
59. Leschziner, A., Moukhles, H., Lindenbaum, M., Gee, S.H., Butterworth, J., Campbell, K.P. and Carbonetto, S. (2000) Neural regulation of α-dystroglycan biosynthesis and glycosylation in skeletal muscle. J. Neurochem., 74, 70-80.
60. Brancaccio, A., Schulthess, T., Gesemann, M. and Engel, J. (1995) Electron microscopic evidence for a mucin-like region in chick muscle α-dystroglycan. FEBS Lett., 368, 139-142.
61. Talts, J., Andac, Z., Göhring, W., Brancaccio, A. and Timpl, R. (1999) Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α-dystroglycan and several extracellular matrix proteins. EMOO J., 18, 863-870.
62. Brown, S.C., Fassati, A., Popplewell, L., Page, A.M., Henry, M.D., Campbell, K.P. and Dickson, G. (1999) Dystrophic phenotype induced by antibody blockade of muscle α-dystroglycan-laminin interaction. J. Cell Sci., 112, 209-216.
63. Sutton-Smith, M., Morris, H.R., Grewal, P.K., Hewitt, J.E., Bittner, R.E., Goldin, E., Schiffmann, R. and Dell, A. (2002) MS screening strategies: investigating the glycomes of knockout and myodystrophic mice and leukodystrophic human brains. Biochemical Society Symposium, 69, 105-115.
64. Martin, P.T. (2003) Dystrogycan glycosylation and its role in matrix binding in skeletal muscle. Glycobiology, 13, 55R-66R.
65. Smalheiser, N.R., Haslam, S.M., Sutton-Smith, M., Morris, H.R. and Dell, A. (1998) Structural analysis of sequences O-linked to mannose reveals a novel Lewis X structure in cranin (dystroglycan) purified from sheep brain. J. Biol. Chem., 273, 23698-23703.
66. Chiba, A.K., Matsumura, H., Yamada, T., Inazu, T., Shimizu, S., Kusunoki, I., Kanazawa, A., Kobata, A. and Endo, T. (1997) Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. J. Biol. Chem., 272, 2156-2162.
67. Sasaki, T., Yamada, H., Matsumura, K., Shimizu, T., Kobata, A. and Endo, T. (1998) Detection of O-mannosyl glycans in rabbit skeletal muscle α-dystroglycan. Biochim. Biophys. Acta, 1425, 599-606.
68. Yamada, H., Chiba, A., Endo, T., Kobata, A., Anderson, L.V.B., Hori, H., Fukata-Ori, H., Kanazawa, I., Campbell, K.P., Shimizu, T. et al. (1996) Characterisation of dystroglycan-laminin interaction in peripheral nerve. J. Neurochem., 66, 1518-1524.
69. 2J mice. Hum. Mol. Genet., 4, 1055-1061.
70. Xu, H., Wu, X-R., Wewer, U.M. and Engvall, E. (1994) Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2) gene. Nature Genet., 8, 297-301.
71. Helbling-Leclerc, A., Zhang, X., Topaloglu, H., Cruaud, C., Tesson, F., Weissenbach, J., Tomé, F.M.S., Schwartz, K., Fardeau, M., Tryggvason, K. et al. (1995) Mutations in the laminin α2-chain (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nature Genet., 11, 216-218.
72. Henion, T.R., Qu, Q. and Smith, F.I. (2003) Expression of dystroglycan, fakutin and POMGnT1 during mouse cerebellar development. Mol. Brain. Res., 112, 177-181.